Immunosenescence Inventory-a multi-omics database for immune aging research.

Hao Li, Wei Zhao, Fei Yang, Qin Qiao, Shuai Ma, Kuan Yang, Shuhui Song, Si Wang, Jing Qu, Guang-Hui Liu, Yiming Bao, Weiqi Zhang

China National Center for Bioinformation, Beijing 100101, China.China National Center for Bioinformation, Beijing 100101, China. · pubmed

Paper

Abstract

The immune system is intricately interconnected with all other bodily systems. As individuals age, the immune system undergoes changes known as immunosenescence, increasing susceptibility to disease, and contributing significantly to the morbidity and mortality observed in older populations. Immunosenescence drives systemic aging and therefore represents a key therapeutic target to extend healthy aging. In recent years, the extensive application of omics technologies has broadened our understanding of aging and immunity, necessitating a comprehensive database to encapsulate these advancements and deepen our insights into immune aging in the era of artificial intelligence. The Immunosenescence Inventory is a pioneering database designed to provide a multidimensional and integrative view of the aging immune system. By leveraging cutting-edge omics technologies and analytical tools, Immunosenescence Inventory offers a comprehensive resource for researchers to explore the intricate relationship between immunosenescence and age-related health outcomes. Furthermore, the database, which aids in the creation of diagnostic tools for immune aging conditions, is now publicly available at https://ngdc.cncb.ac.cn/iaa/home.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper presents the Immunosenescence Inventory, a multi-omics database that aims to deepen the understanding of immunosenescence and its implications for aging and age-related health outcomes. This focus on the immune system's aging process aligns with the broader goals of longevity research, as it seeks to address the root causes of aging rather than merely treating symptoms. However, while the creation of such a database is a solid contribution to the field, it is primarily a resource tool rather than presenting groundbreaking findings or novel therapeutic approaches, which limits its overall impact.

Author of this paper? Send a correction.